Clinical Trial Update: Creatine Monohydrate Use for Preventing Altitude Induced Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating creatine monohydrate to prevent altitude-induced depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Creatine monohydrate (creatine monohydrate)

Snippet

Sponsor: Mike O'Callaghan Military Hospital | Conditions: Depression | Phase 4 | Status: WITHDRAWN